Antirheumatic Drugs: Clinical Pharmacology and Therapeutic Use

[1]  高橋 季之,et al.  Anti-inflammatory drugs , 2013 .

[2]  W. Loan,et al.  Strong Analgesics: Pharmacological and Therapeutic Aspects , 1973, Drugs.

[3]  J. Vane.  The mode of action of aspirin-like drugs , 1978, Agents and Actions.

[4]  F. Mcmahon,et al.  Kinetics of indomethacin absorption, elimination, and enterohepatic circulation in man , 1976, Journal of Pharmacokinetics and Biopharmaceutics.

[5]  J. Sassard,et al.  Pharmacokinetics of fenbufen in man , 1979, European Journal of Clinical Pharmacology.

[6]  J. Wagner,et al.  Pharmacokinetics of tolmetin with and without concomitant administration of antacid in man , 1977, European Journal of Clinical Pharmacology.

[7]  A. Szczeklik.  [Aspirin-induced asthma]. , 1986, Pneumonologia polska.

[8]  M. Urowitz,et al.  Acute leukemia in rheumatoid arthritis treated with cytotoxic agents. , 1984, The Journal of rheumatology.

[9]  A. D. Kornblut,et al.  Wegener's granulomatosis. , 1974, Otolaryngologic clinics of North America.

[10]  G. D'Amico,et al.  Analgesic nephropathy. , 1981, British medical journal.

[11]  C. Robertson,et al.  MEFENAMIC ACID NEPHROPATHY , 1980, The Lancet.

[12]  J. Callen,et al.  Methotrexate in psoriasis. A brief review of indications, usage, and complications of methotrexate therapy. , 1980, Journal of the American Academy of Dermatology.

[13]  V. Marks,et al.  Plasma steroid levels after intra-articular injection of prednisolone acetate in patients with rheumatoid arthritis. , 1980, Annals of the rheumatic diseases.

[14]  T. Anastassiades,et al.  The toxicity pattern of d-penicillamine therapy , 1980 .

[15]  T. Anastassiades,et al.  The toxicity pattern of D-penicillamine therapy. A guide to its use in rheumatoid arthritis. , 1980, Arthritis and rheumatism.

[16]  H. Robinson,et al.  Adverse effects of D-penicillamine in rheumatoid arthritis. , 1980, Annals of internal medicine.

[17]  D. Ferry,et al.  The aspirin-ibuprofen interaction in rheumatoid arthritis. , 1979, British journal of clinical pharmacology.

[18]  K. Ivey,et al.  Incidence of gastric lesions in patients with rheumatic disease on chronic aspirin therapy. , 1979, Annals of internal medicine.

[19]  K. Muirden,et al.  Difficulties in the use of D-penicillamine in the treatment of rheumatoid arthritis. , 1979, Australian and New Zealand journal of medicine.

[20]  J. Golding,et al.  Maintenance dose of penicillamine in rheumatoid arthritis: a comparison between a standard and a response-related flexible regimen. , 1979, Annals of the rheumatic diseases.

[21]  W. Buchanan,et al.  Patient compliance: a novel method of testing non-steroidal antiinflammatory analgesics in rheumatoid arthritis. , 1979, The Journal of rheumatology.

[22]  A. J. Gordon,et al.  Piroxicam in the Treatment of Osteoarthrosis: A Multicentre Study in General Practice Involving 1218 Patients , 1979, The Journal of international medical research.

[23]  B. Haynes,et al.  Cyclophosphamide therapy of severe systemic necrotizing vasculitis. , 1979, The New England journal of medicine.

[24]  D. Grauman,et al.  Bladder complications in patients receiving cyclophosphamide for systemic lupus erythematosus or rheumatoid arthritis. , 1979, Annals of internal medicine.

[25]  R. Reinecke,et al.  Ophthalmologic safety of long-term hydroxychloroquine treatment. , 1979, Arthritis and rheumatism.

[26]  A. Kay.  Myelotoxicity of D-penicillamine. , 1979, Annals of the rheumatic diseases.

[27]  T. Twomey,et al.  Piroxicam Pharmacokinetics in Man: Aspirin and Antacid Interaction Studies , 1979, Journal of clinical pharmacology.

[28]  T. Anastassiades,et al.  Long term chrysotherapy: incidence of toxicity and efficacy during sequential time periods. , 1979, Arthritis and rheumatism.

[29]  R. Gibbons.  Complications of chrysotherapy: a review of recent studies. , 1979, Archives of internal medicine.

[30]  G. Bálint,et al.  Myasthenia Associated with Dpenicillamine Therapy in Rheumatoid Arthritis , 1979 .

[31]  E. Jellum,et al.  Some aspects of the mechanism of action of penicillamine in rheumatoid arthritis. , 1979, Scandinavian journal of rheumatology. Supplement.

[32]  H. Hill.  Penicillamine in rheumatoid arthritis: adverse effects. , 1979, Scandinavian journal of rheumatology. Supplement.

[33]  W. Buchanan,et al.  A double-blind, crossover trial of mefenamic acid, sulindac and flurbiprofen in rheumatoid arthritis. , 1979, Current medical research and opinion.

[34]  H. Gärtner,et al.  Penicillamine induced membranous glomerulonephritis. , 1979, Scandinavian journal of rheumatology. Supplement.

[35]  W. Buchanan,et al.  A crossover clinical trial of piroxicam, indomethacin and ibuprofen in rheumatoid arthritis. , 1979, Current medical research and opinion.

[36]  K. E. Holley,et al.  Treatment of diffuse proliferative lupus nephritis with prednisone and combined prednisone and cyclophosphamide. , 1978, The New England journal of medicine.

[37]  M. Weinberger.  Analgesic sensitivity in children with asthma. , 1978, Pediatrics.

[38]  H. Schumacher,et al.  Chrysotherapy in psoriatic arthritis , 1978 .

[39]  V. Wright,et al.  Indomethacin or prednisolone at night in rheumatoid arthritis? , 1978, Rheumatology and rehabilitation.

[40]  E. Huskisson,et al.  Sulindac. Trials of a new anti-inflammatory drug. , 1978, Annals of the rheumatic diseases.

[41]  F. Gribnau,et al.  Double-blind trial of naproxen and phenylbutazone in ankylosing spondylitis. , 1978, Annals of the rheumatic diseases.

[42]  J. Gumpel.  Deaths associated with gold treatment: a reassessment. , 1978, British medical journal.

[43]  E. Veys,et al.  Experience and recommendations for treatment schedule of levamisole in rheumatoid arthritis. , 1978, The Journal of rheumatology. Supplement.

[44]  A multicentre randomized double-blind study comparing two dosages of levamisole in rheumatoid arthritis. , 1978, The Journal of rheumatology. Supplement.

[45]  G. Goldstein.  Mode of action of levamisole. , 1978, The Journal of rheumatology. Supplement.

[46]  E. Veys,et al.  A study of the hematological side effects of levamisole in rheumatoid arthritis with recommendations. , 1978, The Journal of rheumatology. Supplement.

[47]  M. Rosenthal.  A critical review of the effect of levamisole in rheumatic diseases other than rheumatoid arthritis. , 1978, The Journal of rheumatology. Supplement.

[48]  M. Ehrnebo,et al.  Bioavailability and first‐pass metabolism of oral pentazocine in man , 1977, Clinical pharmacology and therapeutics.

[49]  W. Krause,et al.  Protective effect of cimetidine on aspirin-induced gastric mucosal damage. , 1977, Annals of internal medicine.

[50]  H. Paulus,et al.  A double-blind trial of high versus conventional dosages of gold salts for rheumatoid arthritis. , 1977, Arthritis and rheumatism.

[51]  J. W. Findlay,et al.  Codeine kinetics as determined by radioimmunoassay , 1977, Clinical pharmacology and therapeutics.

[52]  G. Graham,et al.  Patterns of plasma concentrations and urinary excretion of salicylate in rheumatoid arthritis , 1977, Clinical pharmacology and therapeutics.

[53]  B. Gordon,et al.  Treatment of systemic lupus erythematosus with the T-cell immunopotentiator levamisole: a follow-up report of 16 patients under treatment for a minimum period of four months. , 1977, Annals of allergy.

[54]  J. D. Barker,et al.  Chronic excessive acetaminophen use and liver damage. , 1977, Annals of internal medicine.

[55]  R. Grahame,et al.  A trial of feprazone in ankylosing spondylitis. , 1977, Rheumatology and rehabilitation.

[56]  J. Sharp,et al.  Comparison of two dosage schedules of gold salts in the treatment of rheumatoid arthritis. Relationship of serum gold levels to therapeutic response. , 1977, Arthritis and rheumatism.

[57]  H. DeLuca,et al.  Intestinal calcium absorption in exogenous hypercortisonism. Role of 25-hydroxyvitamin D and corticosteroid dose. , 1977, The Journal of clinical investigation.

[58]  W. Inman.  Study of fatal bone marrow depression with special reference to phenylbutazone and oxyphenbutazone. , 1977, British medical journal.

[59]  H. Bird,et al.  Failure of D-penicillamine to affect peripheral joint involvement in ankylosing spondylitis or HLA B27-associated arthropathy. , 1977, Annals of the rheumatic diseases.

[60]  R. Miller.  Propoxyphene: a review. , 1977, American journal of hospital pharmacy.

[61]  M. Urowitz,et al.  Azathioprine in early rheumatoid arthritis , 1977 .

[62]  M. Rosenthal,et al.  Levamisole in the modulation of the immune response: the current experimental and clinical state. , 1977, Journal of the Reticuloendothelial Society.

[63]  M. C. Kyle,et al.  Clinical study of ticrynafen. A new diuretic, antihypertensive, and uricosuric agent. , 1977, JAMA.

[64]  A. Jain,et al.  On the question of an interaction between sulindac and tolbutamide in the control of diabetes , 1977, Clinical pharmacology and therapeutics.

[65]  Davies Ds.  Phenylbutazone: factors influencing plasma concentrations. , 1977 .

[66]  H. Isomäki,et al.  Effect of gold treatment on the progression of erosions in RA patients. , 1977, Scandinavian journal of rheumatology.

[67]  M. Walter,et al.  Interaction study between phenprocoumon and flurbiprofen. , 1977, Current medical research and opinion.

[68]  N. Cardoe,et al.  Butacote: A Six-Year Follow-Up of Patients with Gastric Intolerance to other Medications , 1977, The Journal of international medical research.

[69]  E. Huskisson.  Antiinflammatory drugs. , 1977, Seminars in arthritis and rheumatism.

[70]  N. Rothermich,et al.  Chrysotherapy. A prospective study. , 1976, Arthritis and rheumatism.

[71]  P. Bacon,et al.  Penicillamine Nephropathy in Rheumatoid Arthritis , 1976 .

[72]  P. Bacon,et al.  Penicillamine nephropathy in rheumatoid arthritis. A clinical, pathological and immunological study. , 1976, The Quarterly journal of medicine.

[73]  J. Anderson,et al.  Evaluation of analgesic action and efficacy of antirheumatic drugs. Study of 10 drugs in 684 patients with rheumatoid arthritis. , 1976, The Journal of rheumatology.

[74]  E. Tan,et al.  Oral aspirin challenges in asthmatic patients: a study of plasma histamine , 1976, Clinical allergy.

[75]  W. Downie,et al.  Effects of enzyme induction on metabolism of prednisolone. Clinical and laboratory study. , 1976, Annals of the rheumatic diseases.

[76]  R. Willkens,et al.  Combination therapy with naproxen and aspirin in rheumatoid arthritis. , 1976, Arthritis and rheumatism.

[77]  D. T. Walz,et al.  Auranofin. New oral gold compound for treatment of rheumatoid arthritis. , 1976, Annals of the rheumatic diseases.

[78]  A. Kay.  Myelotoxicity of gold. , 1976, British medical journal.

[79]  E. Huskisson,et al.  Four new anti-inflammatory drugs: responses and variations. , 1976, British medical journal.

[80]  J. Lawrence.  Comparative toxicity of gold preparations in treatment of rheumatoid arthritis. , 1976, Annals of the rheumatic diseases.

[81]  U. Zor,et al.  Inhibition of prostaglandin E release by anti-inflammatory steroids. , 1976, Prostaglandins.

[82]  H O Conn,et al.  Nonassociation of adrenocorticosteroid therapy and peptic ulcer. , 1976, The New England journal of medicine.

[83]  L. Shulman,et al.  Controlled trial of cyclophosphamide in rheumatoid arthritis. , 1976, Arthritis and rheumatism.

[84]  J. Anderson,et al.  An assessment of the therapeutic potential of azapropazone in rheumatoid arthritis. , 1976, Current medical research and opinion.

[85]  G. E. Gresham,et al.  The efficacy of antimalarials in systemic lupus erythematosus. , 1988, The Journal of rheumatology.

[86]  D. Robinson,et al.  Corticosteroids inhibit prostaglandin production by rheumatoid synovia , 1975, Nature.

[87]  P. Abbrecht,et al.  Lack of interaction between ibuprofen and warfarin. , 1975, Current therapeutic research, clinical and experimental.

[88]  S. Wallace.  Colchicine and new antiinflammatory drugs for the treatment of acute gout. , 1975, Arthritis and rheumatism.

[89]  R. M. Mason,et al.  Synthetic D(-)penicillamine in rheumatoid arthritis. Double-blind controlled study of a high and low dosage regimen. , 1975, Annals of the rheumatic diseases.

[90]  Y. Dinai,et al.  LEVAMISOLE IN RHEUMATOID ARTHRITIS , 1975, The Lancet.

[91]  T. Self,et al.  DRUG ENHANCEMENT OF WARFARIN ACTIVITY , 1975, The Lancet.

[92]  Bai Ls,et al.  Tolmetin: an evaluation of a new preparation in the treatment of rheumatoid arthritis. , 1975 .

[93]  E. Vesell,et al.  Failure of Indomethacin and Warfarin to Interact in Normal Human Volunteers , 1975, Journal of clinical pharmacology.

[94]  G. Hunder,et al.  Daily and alternate-day corticosteroid regimens in treatment of giant cell arteritis: comparison in a prospective study. , 1975, Annals of internal medicine.

[95]  R. Lewis,et al.  Warfarin-phenylbutazone interaction in man: a long term multiple dose study. , 1975, Research communications in chemical pathology and pharmacology.

[96]  J. Scott,et al.  Feprazone, a new anti-inflammatory agent. Studies of potency and gastrointestinal tolerance. , 1975, Annals of the rheumatic diseases.

[97]  D. Zutshi,et al.  Myasthenia gravis associated with penicillamine treatment for rheumatoid arthritis. , 1975, British medical journal.

[98]  E. Tolman,et al.  Multiple sites of interaction between prostaglandins and non-steroidal anti-inflammatory agents. , 1975, Prostaglandins.

[99]  Klinefelter.  Reinstitution of gold therapy in rheumatoid arthritis after mucocutaneous reactions. , 1975, The Journal of rheumatology.

[100]  A. Szczeklik,et al.  Relationship of inhibition of prostaglandin biosynthesis by analgesics to asthma attacks in aspirin-sensitive patients. , 1975, British medical journal.

[101]  H. Hundt,et al.  Decreased steady-state salicylic acid plasma levels associated with chronic aspirin ingestion , 1975 .

[102]  M. Urowitz,et al.  Azathioprine in rheumatoid arthritis , 1975 .

[103]  M. Urowitz,et al.  Azathioprine in rheumatoid arthritis: a long-term follow-up study. , 1975, Arthritis and rheumatism.

[104]  R. Collins,et al.  Tolmetin: an evaluation of a new preparation in the treatment of rheumatoid arthritis. , 1975, The British journal of clinical practice.

[105]  G. Sánchez.  Letter: Enhancement of heparin effect by probenecid. , 1975, The New England journal of medicine.

[106]  P. Schein,et al.  Immunosuppressive and cytotoxic chemotherapy: long-term complications. , 1975, Annals of internal medicine.

[107]  J. Vane,et al.  The role of prostaglandins in the local control of circulation. , 1975, Clinical and experimental pharmacology & physiology.

[108]  W. R. Mccrum,et al.  Gold salts in the treatment of rheumatoid arthritis. A double-blind study. , 2020, Annals of internal medicine.

[109]  F. Coe,et al.  Hypercalciuria and hyperuricosuria in patients with calcium nephrolithiasis. , 1974, The New England journal of medicine.

[110]  S. L. Schrier,et al.  Acute myelogenous leukemia in two patients treated with azathioprine for nonmalignant diseases. , 1974, The American journal of medicine.

[111]  E. Huskisson.  Simple Analgesics for Arthritis , 1974, British medical journal.

[112]  Müller Fo,et al.  A multicentre trial of Voltaren in the treatment of rheumatoid Arthritis. , 1974 .

[113]  H. Maibach,et al.  Liver disease in psoriatics--An effect of methotrexate therapy? , 1974, Archives of dermatology.

[114]  Miller Jm,et al.  Acetaminophen with codeine for the relief of severe pain in postpartum patients. , 1974 .

[115]  Glenn Em,et al.  Aspirin-flurbiprofen interaction in the adjuvant-induced polyarthritic rat. , 1974 .

[116]  C. Pearson,et al.  Polymyositis and dermatomyositis: combined methotrexate and corticosteroid therapy. , 1974, Annals of internal medicine.

[117]  Calvin G. Barnes,et al.  Treatment of psoriatic arthropathy with either azathioprine or methotrexate. , 1974, Rheumatology and rehabilitation.

[118]  B. Skrifvars,et al.  Gold nephropathy prototype of membranous glomerulonephritis. , 1974, The American journal of pathology.

[119]  L. Solomon,et al.  Voltaren in the treatment of rheumatoid arthritis. , 1974, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[120]  A. Steinberg,et al.  Cyclophosphamide: use in practice. , 1974, Annals of internal medicine.

[121]  H. Sevelius,et al.  Naproxen‐aspirin interactions in man , 1974, Clinical pharmacology and therapeutics.

[122]  Girdwood Rh.  Death after taking medicaments. , 1974 .

[123]  A. Ackerman,et al.  Gold dermatitis. A clinical and histopathological study. , 1974, Archives of dermatology.

[124]  O. Meyers,et al.  A multicentre trial of Voltaren in the treatment of rheumatoid Arthritis. , 1974, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[125]  H. Levin,et al.  Acetaminophen with codeine for the relief of severe pain in postpartum patients. , 1974, Current therapeutic research, clinical and experimental.

[126]  A. Levi,et al.  Impairment of hepatic uptake of rifamycin antibiotics by probenecid, and its therapeutic implications. , 1973, Lancet.

[127]  F. Arnett,et al.  Methotrexate therapy in polymyositis. , 1973, Annals of the rheumatic diseases.

[128]  S. Desai.  Sudden gigantism of breasts: drug induced? , 1973, British journal of plastic surgery.

[129]  B. Rodda,et al.  Interactions of aspirin with nonsteroidal antiinflammatory drugs in man. , 1973, Arthritis and rheumatism.

[130]  H. Paulus,et al.  Simultaneous pharmacokinetics of indomethacin in serum and synovial fluid. , 1973, Annals of the rheumatic diseases.

[131]  W. Downie,et al.  Clinical trial of pentazocine in rheumatoid arthritis. Observations on the value of potent analgesics and placebos. , 1973, Annals of the rheumatic diseases.

[132]  J. Sharp,et al.  Double-blind study of cyclophosphamide in rheumatoid arthritis. , 1973, Arthritis and rheumatism.

[133]  A. Horsman,et al.  Corticosteroid osteoporosis. , 1973, Clinics in endocrinology and metabolism.

[134]  J. Almeyda,et al.  STRUCTURAL AND FUNCTIONAL ABNORMALITIES OF THE LIVER IN PSORIASIS BEFORE AND DURING METHOTREXATE THERAPY , 1972, The British journal of dermatology.

[135]  D. Feldman,et al.  Subcellular mechanisms in the action of adrenal steroids. , 1972, The American journal of medicine.

[136]  P. Schraeder,et al.  Polymyositis and penicillamine. , 1972, Archives of neurology.

[137]  D. Croft,et al.  Gastric Bleeding and Benorylate, a New Aspirin , 1972, British medical journal.

[138]  N. Sládek.  Therapeutic efficacy of cyclophosphamide as a function of inhibition of its metabolism. , 1972, Cancer research.

[139]  M. Greenberg,et al.  Aplastic agranulocytosis after allopurinol therapy. , 1972, Arthritis and rheumatism.

[140]  B R Mascarenhas,et al.  Gold metabolism in patients with rheumatoid arthritis treated with gold compounds--reinvestigated. , 1972, Arthritis and rheumatism.

[141]  J. Stratigos,et al.  FURTHER EXPERIENCES OF TOXIC EPIDERMAL NECROLYSIS INCRIMINATING ALLOPURINOL, PYRAZOLONE AND DERIVATIVES , 1972, The British journal of dermatology.

[142]  D. Mccarty.  Treatment of rheumatoid joint inflammation with triamcinolone hexacetonide. , 1972, Arthritis and rheumatism.

[143]  H. E. Merlin.  Azoospermia caused by colchicine--a case report. , 1972, Fertility and sterility.

[144]  G. Levy,et al.  Limited capacity for salicyl phenolic glucuronide formation and its effect on the kinetics of salicylate elimination in man , 1972, Clinical pharmacology and therapeutics.

[145]  A. Gutman,et al.  Observations on the disposition of probenecid in patients receiving allopurinol. , 1972, Pharmacology.

[146]  Buchanan Ww,et al.  Advances in the treatment of rheumatic disorders. , 1971 .

[147]  W. Jusko,et al.  Prednisone side-effects and serum-protein levels. A collaborative study. , 1971, Lancet.

[148]  J. Wyngaarden,et al.  Drug treatment of gout. , 1971, Seminars in drug treatment.

[149]  H. Paulus,et al.  Variations of serum concentrations and half-life of salicylate in patients with rheumatoid arthritis. , 1971, Arthritis and rheumatism.

[150]  J. Vane,et al.  Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. , 1971, Nature: New biology.

[151]  O. Mjølnerød,et al.  Congenital connective-tissue defect probably due to D-penicillamine treatment in pregnancy. , 1971, Lancet.

[152]  J. Walshe,et al.  Studies with 35S-labelled DL-penicillamine in patients with Wilson's disease. , 1971, The Quarterly journal of medicine.

[153]  D. Edmar.  Effects of Salicylates on the Gastric Mucosa as Revealed by Roentgen Examination and the Gastrocamera , 1971, Acta radiologica: diagnosis.

[154]  J. S. Orr.  Occupancy approach to colchicine dosage. , 1971, Lancet.

[155]  C. Pearson,et al.  Treatment of corticosteroid-resistant polymyositis with methotrexate. , 1971, Lancet.

[156]  E. Vesell,et al.  Impairment of drug metabolism in man by allopurinol and nortriptyline. , 1970, The New England journal of medicine.

[157]  D. Silverberg,et al.  Gold nephropathy. A clinical and pathologic study. , 1970, Arthritis and rheumatism.

[158]  J. Mcgiff,et al.  Prostaglandin‐Like Substances Appearing in Canine Renal Venous Blood During Renal Ischemia: Their Partial Characterization By Pharmacologic And Chromatographic Procedures , 1970, Circulation research.

[159]  R. Ney,et al.  Alternate-day vs shorter-interval steroid administration. , 1970, Archives of internal medicine.

[160]  E. Huskisson,et al.  Evening indomethacin in the treatment of rheumatoid arthritis. , 1970, Annals of the rheumatic diseases.

[161]  M. Åkerman,et al.  LIVER BIOPSY IN PSORIASIS , 1970, The British journal of dermatology.

[162]  D. Wombolt,et al.  Vasculitis with allopurinol therapy. , 1970, American heart journal.

[163]  M. Nevins,et al.  Phenylbutazone and pulmonary oedema. , 1969, Lancet.

[164]  J. R. Leonards.  Absence of gastrointestinal bleeding following administration of salicylsalicylic acid. , 1969, The Journal of laboratory and clinical medicine.

[165]  A. Gutman,et al.  Studies of interactions among drugs in man at the renal level: Probenecid and sulfinpyrazone , 1969, Clinical pharmacology and therapeutics.

[166]  C. Goodwin,et al.  Inhibition of dapsone excretion by probenecid. , 1969, The Lancet.

[167]  R. Sweetnam.  Corticosteroid arthropathy and tendon rupture. , 1969, The Journal of bone and joint surgery. British volume.

[168]  M. Samter.  The acetyl- in aspirin. , 1969, Annals of internal medicine.

[169]  Seegmiller Je,et al.  Urinary xanthine stones--a rare complications of allopurinol therapy. , 1969 .

[170]  Calvin G. Barnes,et al.  Azathioprine in Rheumatoid Arthritis , 1969, British medical journal.

[171]  D. Hoefnagel.  Trisomy after colchicine therapy. , 1968, Lancet.

[172]  A. Kumagai.  [Glucocorticoid therapy]. , 1969, Jibi inkoka Otolaryngology.

[173]  O. Frota-Pessoa,et al.  Trisomy after colchicine therapy. , 1969, Lancet.

[174]  F. Bull,et al.  Cirrhosis associated with methotrexate treatment of psoriasis. , 1968, JAMA.

[175]  R. Schwartz,et al.  Treatment of dermatomyositis with methotrexate. , 1968, Lancet.

[176]  G. Hitchings,et al.  Renal clearance of oxipurinol, the chief metabolite of allopurinol. , 1968, The American journal of medicine.

[177]  M. Schwartz,et al.  Apparent effect of probenecid on the distribution of penicillins in man , 1968, Clinical pharmacology and therapeutics.

[178]  M. Samter,et al.  Intolerance to aspirin. Clinical studies and consideration of its pathogenesis. , 1968, Annals of internal medicine.

[179]  S. Malawista,et al.  Colchicine: a common mechanism for its anti-inflammatory and anti-mitotic effects. , 1968, Arthritis and rheumatism.

[180]  L. A. Healey,et al.  The renal excretion of indomethacin and its inhibition by probenecid , 1968, Clinical pharmacology and therapeutics.

[181]  G. Kersley.  Amethopterin (methotrexate) in connective tissue disease-psoriasis and polyarthritis. , 1968, Annals of the rheumatic diseases.

[182]  R. Rees,et al.  Methotrexate in psoriasis. , 1968, Lancet.

[183]  E. McChesney,et al.  The metabolism of chloroquine in man during and after repeated oral dosage. , 1967, The Journal of pharmacology and experimental therapeutics.

[184]  V. James,et al.  Recovery of hypothalamo-pituitary-adrenal function after corticosteroid therapy. , 1967, Lancet.

[185]  E. Dubois,et al.  Ocular changes induced by long-term hydroxychloroquine (plaquenil) therapy. , 1967, American journal of ophthalmology.

[186]  F. Hart,et al.  Side-effects of indomethacin. , 1967, Annals of the rheumatic diseases.

[187]  H. Diamond,et al.  Diagnostic value of the colchicine therapeutic trial. , 1967, JAMA.

[188]  H. Brendler,et al.  Treatment of uric acid urolithiasis with allopurinol: a xanthine oxidase inhibitor. , 1967, The Journal of urology.

[189]  U. Nylander.  OCULAR DAMAGE IN CHLOROQUINE THERAPY , 1966, Acta ophthalmologica.

[190]  L. Seebach.  Allopurinol in the treatment of gout. , 1967, The Journal-lancet.

[191]  K. Sandvig.  Chloroquine (resochin) effects on the cornea. , 2009, Acta ophthalmologica.

[192]  R. M. Mason,et al.  Mefenamic acid and flufenamic acid compared with aspirin and phenylbutazone in rheumatoid arthritis. , 1966, British medical journal.

[193]  G. Hitchings,et al.  Metabolic studies of allopurinol, an inhibitor of xanthine oxidase. , 1966, Biochemical pharmacology.

[194]  H. Voipio.  INCIDENCE OF CHLOROQUINE RETINOPATHY , 1966, Acta ophthalmologica.

[195]  K. Millingen,et al.  PERIPHERAL NEUROMYOPATHY FOLLOWING CHLOROQUINE THERAPY , 1966, The Medical journal of Australia.

[196]  H. Baker.  THE INFLUENCE OF CHLOROQUINE AND RELATED DRUGS ON PSORIASIS AND KERATODERMA BLENORRHAGICUM. , 1966 .

[197]  T. B. Bayles,et al.  Salicylate therapy in rheumatoid arthritis. , 1968, The Medical clinics of North America.

[198]  J. Klinenberg,et al.  Effect of corticosteroids on blood salicylate concentration. , 1965, JAMA.

[199]  A. Gutman.  Treatment of primary gout: The present status (The W. Paul Holbrook Memorial Lecture) , 1965 .

[200]  N. D’Esopo,et al.  Certain endocrine and metabolic facets of the steroid withdrawal syndrome. , 1965, The Journal of clinical endocrinology and metabolism.

[201]  C. Hawkins,et al.  Indomethacin: Studies of Absorption and of the Use of Indomethacin Suppositories , 1965, British medical journal.

[202]  J. J. Bunim,et al.  SJÖGREN'S SYNDROME: A Clinical, Pathological, and Serological Study of Sixty-two Cases , 1965, Medicine.

[203]  H. Smythe,et al.  THE EFFECT OF SULFINPYRAZONE (ANTURAN) ON PLATELET ECONOMY AND BLOOD COAGULATION IN MAN. , 1965, Canadian Medical Association journal.

[204]  A. Conney,et al.  APPLICATION OF DRUG METABOLISM TO DRUG TOXICITY STUDIES , 1965, Annals of the New York Academy of Sciences.

[205]  R. Auerbach.  PARENTERAL VS. ORAL FOLIC ACID ANTAGONISTS. , 1964, Archives of dermatology.

[206]  A. Eisen,et al.  METHOTREXATE THERAPY IN PSORIATIC ARTHRITIS; DOUBLE-BLIND STUDY ON 21 PATIENTS. , 1964, JAMA.

[207]  I. Jaffe.  RHEUMATOID ARTHRITIS WITH ARTERITIS; REPORT OF A CASE TREATED WITH PENICILLAMINE. , 1964, Annals of internal medicine.

[208]  D. Mccarty,et al.  INFLAMMATORY REACTION AFTER INTRASYNOVIAL INJECTION OF MICROCRYSTALLINE ADRENOCORTICOSTEROID ESTERS. , 1964, Arthritis and rheumatism.

[209]  T. Danowski,et al.  PROBABILITIES OF PITUITARY-ADRENAL RESPONSIVENESS AFTER STEROID THERAPY. , 1964, Annals of internal medicine.

[210]  J. Percy,et al.  Indomethacin in the Treatment of Rheumatic Diseases , 1964, Annals of the rheumatic diseases.

[211]  R. O'rourke,et al.  METHOTREXATE-INDUCED HEPATIC INJURY IN AN ADULT. A CASE REPORT. , 1964, Archives of Internal Medicine.

[212]  M. Kristensen,et al.  SULPHAPHENAZOLE-INDUCED HYPOGLYCAEMIC ATTACKS IN TOLBUTAMIDE-TREATED DIABETICS. , 1963, Lancet.

[213]  F. Hart,et al.  Indomethacin: A New Non-steroid Anti-inflammatory Agent , 1963, British medical journal.

[214]  E. Risley,et al.  ANTI-INFLAMMATORY AND ANTIPYRETIC ACTIVITIES OF INDOMETHACIN, 1-(P-CHLOROBENZOYL)-5-METHOXY-2-METHYLINDOLE-3-ACETIC ACID. , 1963, The Journal of pharmacology and experimental therapeutics.

[215]  A. Gutman,et al.  MUTUAL SUPPRESSION OF THE URICOSURIC EFFECTS OF SULFINPYRAZONE AND SALICYLATE: A STUDY IN INTERACTIONS BETWEEN DRUGS. , 1963, The Journal of clinical investigation.

[216]  A. Gutman,et al.  The physiological disposition of probenecid, including renal clearance, in man, studied by an improved method for its estimation in biological material. , 1963, The Journal of pharmacology and experimental therapeutics.

[217]  M. Finland,et al.  AMPICILLIN ACTIVITY IN VITRO AND ABSORPTION AND EXCRETION IN NORMAL YOUNG MEN , 1963, The American journal of the medical sciences.

[218]  N. Zvaifler,et al.  The metabolism of chloroquin , 1962 .

[219]  J. Scott,et al.  Hydroxychloroquine sulfate (“Plaquenil”) in treatment of rheumatoid arthritis , 1962 .

[220]  A. Gutman,et al.  Efficacy of colchicine prophylaxis in gout. Prevention of recurrent gouty arthritis over a mean period of five years in 208 gouty subjects. , 1961, Annals of internal medicine.

[221]  P. Dayton,et al.  Metabolism of sulfinpyrazone (Anturane) and other thio analogues of phenylbutazone in man. , 1961, The Journal of pharmacology and experimental therapeutics.

[222]  E. Glick.  Sulphinpyrazone in the Treatment of Arthritis Associated with Hyperuricæmia , 1961, Proceedings of the Royal Society of Medicine.

[223]  R. Persellin,et al.  The use of sulfinpyrazone in the treatment of gout. , 1961, JAMA.

[224]  F. Bier,et al.  Chloroquine Diphosphate in Rheumatoid Arthritis * , 1961, Annals of the rheumatic diseases.

[225]  J. Hollander,et al.  Intra-synovial corticosteroid therapy: a decade of use. , 1961, Bulletin on the rheumatic diseases.

[226]  A. Freedman,et al.  Chloroquine in Rheumatoid Arthritis , 1960, Annals of the rheumatic diseases.

[227]  L. Lockie.  Use of gold in the treatment of rheumatoid arthritis. , 1960, The Journal of the Florida Medical Association. Florida Medical Association.

[228]  A Comparison of Prednisolone with Aspirin or other Analgesics in the Treatment of Rheumatoid Arthritis , 1959, Annals of the rheumatic diseases.

[229]  R. M. Mason.  Drug Treatment of Gout , 1959, British medical journal.

[230]  J. Dall,et al.  Disturbances of Pigmentation with Chloroquine , 1959, British medical journal.

[231]  A. Freedman,et al.  Chloroquine in Rheumatoid Arthritis , 1959 .

[232]  A. Gutman,et al.  Results of a clinical trial of G-28315, a sulfoxide analog of phenylbutazone, as a uricosuric agent in gouty subjects. , 1958, Arthritis and rheumatism.

[233]  A. Cohen,et al.  A controlled study of chloroquine as an antirheumatic agent. , 1958, Arthritis and rheumatism.

[234]  D. Schachter,et al.  Salicylate and salicyl conjugates: fluorimetric estimation, biosynthesis and renal excretion in man. , 1958, The Journal of clinical investigation.

[235]  A. Gutman,et al.  Protracted uricosuric therapy in tophaceous gout. , 1957, Lancet.

[236]  H. P. Wagener,et al.  Treatment of temporal arteritis with adrenal corticosteroids; results in fifty-five cases in which lesion was proved at biopsy. , 1957, Journal of the American Medical Association.

[237]  J. P. Currie,et al.  Observations on the Treatment of Rheumatoid Arthritis with Butazolidin , 1953, Annals of the rheumatic diseases.

[238]  A. Freedman,et al.  Mepacrine and rheumatoid arthritis. , 1952, Lancet.

[239]  K. Beyer,et al.  'Benemid,' p-(di-n-propylsulfamyl)-benzoic acid; its renal affinity and its elimination. , 1951, The American journal of physiology.

[240]  P. Hench,et al.  The effect of a hormone of the adrenal cortex (17-hydroxy-11-dehydrocorticosterone; compound E) and of pituitary adrenocorticotropic hormone on rheumatoid arthritis. , 1949, Proceedings of the staff meetings. Mayo Clinic.

[241]  P. Hench,et al.  The effect of a hormone of the adrenal cortex (17-hydroxy-11-dehydrocorticosterone: compound E) and the pituitary adrenocorticotrophic hormone on rheumatoid arthritis: Preliminary report , 2017 .

[242]  T. N. Fraser.  Gold Treatment in Rheumatoid Arthritis , 1945, Annals of the rheumatic diseases.

[243]  J. Korst,et al.  Double-blind trial of naproxen and phenylbutazone in ankylosing spondylitis , 2022 .